Hadassah Medical Center, aerial view of the Ein Karem campus
The Raphael Lab interior, with the Jerusalem hills visible through the window

Brain Tumor Immunology

Brain Tumor Immunology

·

·

HUJI

HUJI

·

·

Hadassah–Ein Karem

Hadassah–Ein Karem

We study T cell behavior in brain tumors to develop new immunotherapies.

We study T cell behavior in brain tumors to develop new immunotherapies.

We study T cell behavior in brain tumors to develop new immunotherapies.

From pediatric gliomas to adult glioblastoma, our work translates immunology into therapies for aggressive neuro-oncology. We’re a new lab, building actively, with a translational orientation from day one.

From pediatric gliomas to adult glioblastoma, our work translates immunology into therapies for aggressive neuro-oncology. We’re a new lab, building actively, with a translational orientation from day one.

We are recruiting graduate students, postdocs, and rotation students.

The lab is recruiting now — graduate students, postdocs, and rotation students.

We are recruiting graduate students, postdocs, and rotation students.

Target discovery

Target discovery

Decoding the immune dialogue

Decoding the immune dialogue

We decode the complex dialogue between brain tumors and the immune system using multi-omics and single-cell sequencing to uncover the specific evasion mechanisms and predictive biomarkers that current therapies miss.

Raphael I, et al. Sci Transl Med. 2025

Microenvironment cross-talk

Microenvironment cross-talk

Reprogramming the tumor-immune niche

Reprogramming the tumor-immune niche

How the extreme conditions of the glioma microenvironment dictate the success or failure of an immune response — and what reprograms it.

Raphael I, et al. Front Immunol. 2021

Precision immunotherapy

Precision immunotherapy

Designing next-generation therapies

Designing next-generation therapies

Rationally combinatorial approaches, from TCR-engineered T cells to vaccines, designed to overcome the immunosuppressive microenvironment for robust tumor elimination.

Xiong Z, et al. Cell Mol Immunol. 2026

Latest from the lab

Latest from the lab

Latest from the lab

All news →

All news →

JUN 2026

A warm welcome to Dr. Vipin Sharma, joining the lab as a postdoctoral researcher to lead the tumor-immune cross-talk work.

apr 2026

We are thrilled to be selected for the prestigious Zuckerman Faculty STEM Leadership Program to power our research forward.

Mar 2026

Dr. Itay Raphael received the Aryeh Kluger Award for outstanding research in pediatric neuro-oncology as an early-career scientist.

The Raphael Lab

Brain Tumor Immunology

Industry

Funders

Affiliations

The Raphael Lab · Brain Tumor Immunology

Hadassah–Ein Karem · Jerusalem

The Raphael Lab

Brain Tumor Immunology

Industry

Funders

Affiliations

The Raphael Lab · Brain Tumor Immunology

Hadassah–Ein Karem · Jerusalem